Lv5
806 积分 2023-05-16 加入
The role of interleukin-1 beta in inflammation and the potential of immune-targeted therapies
2天前
求助中
IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
11天前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
20天前
已完结
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
26天前
已完结
Population Pharmacokinetics of the TNF‐α and IL‐17A Dual‐Variable Domain Antibody ABT‐122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: Analysis of Phase 1 and 2 Clinical Trials
1个月前
已完结
Hidradenitis suppurativa: TLSs take the center stage
1个月前
已完结
ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases
2个月前
已完结
Preclinical Development of GR2002, a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects
2个月前
已完结
Role of neutrophil interleukin-23 in spondyloarthropathy spectrum disorders
3个月前
已完结
Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1‐antihistamine treatment: results of the phase IV open‐label SUNRISE study
3个月前
已关闭
皖公网安备34019202002308
